Trials / Completed
CompletedNCT00931502
Stent Thrombosis In Acute Coronary Syndromes
Contemporary Treatment Of Stent Thrombosis In Acute Coronary Syndromes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to better understand what treatment methods result in the best outcomes for patients who have heart attacks due to blood clots forming within stents.
Detailed description
This is a multicenter registry that examines treatment strategies and outcomes in patients who present with acute coronary syndrome (ACS) due to stent thrombosis in the coronary arteries. This study will take place at potentially 8 medical centers throughout the State of California. A total of 800 patients will be enrolled into the registry, 100 patients from each of the eight participating California medical centers. UC Davis will serve as the core lab for this study. Eligible subjects, patients who present to the hospital (medical center) with ACS due to stent thrombosis and receive a cardiac catheterization to treat the stent thrombosis, will be included in the retrospective analysis of this cardiac condition. Subjects who expire in hospital due to ACS with stent thrombosis will also be included in the retrospective analysis of this clinical registry. Patients, who consent for approval, will become eligible to participate in the 3-year prospective follow-up phase of the clinical registry. These patients will be followed for three years to learn more about long term clinical outcomes for this disease state. There are no specific/special procedures required for this clinical registry. This is a registry for data collection only to correlate prescribed medical care with individual short- and long-term clinical outcomes.
Conditions
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2009-07-02
- Last updated
- 2018-03-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00931502. Inclusion in this directory is not an endorsement.